Drugs Pharma

Merck pays Moderna $250m for joint development of skin cancer vaccine

Moderna’s mRNA vaccine is being studied in combination with Merck’s Keytruda to treat patients with high-risk melanoma

Read More
Drugs Pharma

Merck’s Covid-19 pill fails initial trial; AstraZenaca’s nasal spray too ineffective

Merck's Covid-19 pill no help in reducing hospitalization or death, Astrazenaca's nasal spray too fails trial

Read More